Singapore markets closed

Augmedix, Inc. (AUGX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.1604-0.0496 (-4.10%)
As of 09:33AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 59.25M
Enterprise value 47.64M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.19
Price/book (mrq)3.33
Enterprise value/revenue 0.98
Enterprise value/EBITDA -2.38

Trading information

Stock price history

Beta (5Y monthly) 0.06
52-week change 3-67.99%
S&P500 52-week change 326.49%
52-week high 36.2500
52-week low 30.9860
50-day moving average 33.2068
200-day moving average 34.5364

Share statistics

Avg vol (3-month) 3639.06k
Avg vol (10-day) 32.23M
Shares outstanding 548.97M
Implied shares outstanding 648.97M
Float 828.91M
% held by insiders 110.12%
% held by institutions 177.95%
Shares short (30 Apr 2024) 41.69M
Short ratio (30 Apr 2024) 45.89
Short % of float (30 Apr 2024) 46.41%
Short % of shares outstanding (30 Apr 2024) 43.45%
Shares short (prior month 28 Mar 2024) 4831.54k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -42.74%
Operating margin (ttm)-34.29%

Management effectiveness

Return on assets (ttm)-23.39%
Return on equity (ttm)-154.69%

Income statement

Revenue (ttm)44.85M
Revenue per share (ttm)1.02
Quarterly revenue growth (yoy)44.90%
Gross profit (ttm)N/A
EBITDA -17.68M
Net income avi to common (ttm)-19.17M
Diluted EPS (ttm)-0.4400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)46.22M
Total cash per share (mrq)0.95
Total debt (mrq)25.85M
Total debt/equity (mrq)110.83%
Current ratio (mrq)2.41
Book value per share (mrq)0.48

Cash flow statement

Operating cash flow (ttm)-15.44M
Levered free cash flow (ttm)-12.56M